Identification of AKB-48 and 5F-AKB-48 metabolites in authentic human urine samples using human liver microsomes and time of flight mass spectrometry

Journal of Analytical Toxicology

Volumn 39, Issue 6, 2015, Pages 426-435

  Vikingsson, Svante ^a   Josefsson, Martin ^a,b   Gréen, Henrik ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Forensic Genetics and Forensic Toxicology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5F AKB 48; AKB 48; CANNABINOID RECEPTOR AGONIST; DRUG METABOLITE; UNCLASSIFIED DRUG; CANNABINOID; DESIGNER DRUG;

ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG IDENTIFICATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; QUADRUPOLE MASS SPECTROMETRY; RETROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TOXICITY TESTING; URINALYSIS; CHEMISTRY; METABOLISM; URINE;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; DESIGNER DRUGS; HUMANS; MICROSOMES, LIVER; TANDEM MASS SPECTROMETRY;

EID: 84939506284     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkv045     Document Type: Article

References (33)

1. Corazza, O., Valeriani, G., Bersani, F.S., Corkery, J., Martinotti, G., Bersani, G. et al. (2014) "Spice", "kryptonite", "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on theweb. Journal of Psychoactive Drugs, 46, 287-294.
2. Gurney, S.M.R., Scott, K.S., Kacinko, S.L., Presley, B.C., Logan, B.K. (2014) Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Science Review, 26, 53-78.
3. Hutter, M., Moosmann, B., Kneisel, S., Auwarter, V. (2013) Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. Journal of Mass Spectrometry, 48, 885-894.
4. Sobolevsky, T., Prasolov, I., Rodchenkov, G. (2012) Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Testing and Analysis, 4, 745-753.
5. Moran, C.L., Le, V.H., Chimalakonda, K.C., Smedley, A.L., Lackey, F.D., Owen, S.N. et al. (2011) Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Analytical Chemistry, 83, 4228-4236.
6. Kavanagh, P., Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., Rozhanets, V. (2013) Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 934, 102-108.
7. Adamowicz, P., Zuba, D., Sekula, K. (2013) Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine. Forensic Science International, 233, 320-327.
8. Kavanagh, P., Grigoryev, A., Melnik, A., Simonov, A. (2012) The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography- mass spectrometry. Journal of Analytical Toxicology, 36, 303-311.
9. Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M. et al. (2011) Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 1126-1136.
10. Grigoryev, A., Kavanagh, P., Melnik, A. (2013) The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography-mass spectrometry. Drug Testing and Analysis, 5, 110-115.
11. Grigoryev, A., Kavanagh, P., Melnik, A. (2012) The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Testing and Analysis, 4, 519-524.
12. Hutter, M., Broecker, S., Kneisel, S., Auwarter, V. (2012) Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. Journal of Mass Spectrometry, 47, 54-65.
13. Sobolevsky, T., Prasolov, I., Rodchenkov, G. (2010) Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Science International, 200, 141-147.
14. Wohlfarth, A., Gandhi, A.S., Pang, S., Zhu, M., Scheidweiler, K.B., Huestis, M.A. (2014) Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry, 406, 1763-1780.
15. Sobolevsky, T., Prasolov, I., Rodchenkov, G. (2015) Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue. Drug Testing and Analysis, 7, 131-142.
16. Holm, N.B., Pedersen, A.J., Dalsgaard, P.W., Linnet, K. (2015) Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry. Drug Testing and Analysis, 7, 199-206.
17. De Brabanter, N., Esposito, S., Tudela, E., Lootens, L., Meuleman, P., Leroux-Roels, G. et al. (2013) In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. Rapid Communications in Mass Spectrometry: RCM, 27, 2115-2126.
18. Jin, M.J., Lee, J., In, M.K., Yoo, H.H. (2013) Characterization of in vitro metabolites of CP 47,497, a synthetic cannabinoid, in human liver microsomes by LC-MS/MS. Journal of Forensic Sciences, 58, 195-199.
19. Kim, U., Jin, M.J., Lee, J., Han, S.B., In, M.K., Yoo, H.H. (2012) Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 64-65, 26-34.
20. Takayama, T., Suzuki, M., Todoroki, K., Inoue, K., Min, J.Z., Kikura-Hanajiri, R. et al. (2014) UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and alpha-PVT, by human liver microsome. Biomedical Chromatography, 28, 831-838.
21. Chimalakonda, K.C., Seely, K.A., Bratton, S.M., Brents, L.K., Moran, C.L., Endres, G.W. et al. (2012) Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition, 40, 2174-2184.
22. ElSohly, M.A., Gul,W., Elsohly, K.M., Murphy, T.P., Madgula, V.L., Khan, S.I. (2011) Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. Journal of Analytical Toxicology, 35, 487-495.
23. Gandhi, A.S., Wohlfarth, A., Zhu, M., Pang, S., Castaneto, M., Scheidweiler, K.B. et al. (2015) High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Testing and Analysis, 7, 187-198.
24. Gandhi, A.S., Zhu, M., Pang, S., Wohlfarth, A., Scheidweiler, K.B., Huestis, M.A. (2014) Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis, 6, 1471-1485.
25. Gandhi, A.S., Zhu, M., Pang, S.,Wohlfarth, A., Scheidweiler, K.B., Liu, H.F. et al. (2013) First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. American Association of Pharmaceutical Scientists Journal, 15, 1091-1098.
26. Wohlfarth, A., Pang, S., Zhu, M., Gandhi, A.S., Scheidweiler, K.B., Huestis, M.A. (2014) Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS. Bioanalysis, 6, 1187-1200.
27. Wohlfarth, A., Pang, S., Zhu, M., Gandhi, A.S., Scheidweiler, K.B., Liu, H.F. et al. (2013) First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and highresolution mass spectrometry. Clinical Chemistry, 59, 1638-1648.
28. Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., Rozhanets, V. (2011) Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 2519-2526.
29. Grigoryev, A., Kavanagh, P., Melnik, A., Savchuk, S., Simonov, A. (2013) Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. Journal of Analytical Toxicology, 37, 265-276.
30. Chimalakonda, K.C., Moran, C.L., Kennedy, P.D., Endres, G.W., Uzieblo, A., Dobrowolski, P.J. et al. (2011) Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Analytical Chemistry, 83, 6381-6388.
31. Amato, J., Iaccarino, N., Pagano, B., Compagnone, V., Di Rosa, F., Peluso, G. et al. (2014) NMR assignment of N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide seized as herbal incense for the first time in Italy. Journal of Forensic Science and Criminology, 1, 1-6.
32. Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y. (2012) Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicology, 30, 114-125.
33. Kronstrand, R., Brinkhagen, L., Birath-Karlsson, C., Roman, M., Josefsson, M. (2014) LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Analytical and Bioanalytical Chemistry, 406, 3599-3609.